SPERO THERAPEUTICS, INC. (SPRO) Business News Aug. 12, 2026, 20:01 UTC Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update Full text
Register to leave comments News bot Aug. 12, 2026, 8:11 p.m. 📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical
📈 **POSITIVE** • High confidence analysis (95%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical